In the BioHarmony Drug Report Database
Isavuconazole
Cresemba (isavuconazole) is a small molecule pharmaceutical. Isavuconazole was first approved as Cresemba on 2015-10-15. It is used to treat aspergillosis and mucormycosis in the USA. It has been approved in Europe to treat aspergillosis.
Trade Name
|
Cresemba |
|---|---|
Common Name
|
isavuconazole |
ChEMBL ID
|
CHEMBL409153 |
Indication
|
aspergillosis, mucormycosis |
Drug Class
|
Systemic antifungals (miconazole type) |
Image (chem structure or protein)